Researchers studied 17,898 Taiwanese adolescents (12 to 17 years) and young adults (18 to 29 years) who were diagnosed with ADHD and 71,592 age and sex-matched non-ADHD controls, who did not have sexually transmitted infections before enrolling in the study. They followed the study subjects from Jan. 1, 2001 through Dec. 31, 2009.
The study shows that adolescents and young adults with ADHD had greater incidence of sexually transmitted infections and developed them at a younger age compared to the controls. However, use of ADHD medication reduced the risk of subsequent sexually transmitted infections among the male ADHD cohort. Short-term ADHD medication use reduced the risk by 30 percent and long-term use reduced it by 41 percent.
“Clinical psychiatrists [should] focus on the occurrence of risky sexual behaviors and the risk of STIs among patients with ADHD and emphasize that treatment with ADHD medications may be a protective factor for prevention of STIs,” said Mu-Hong Chen, MD, lead study author and physician at the Taipei Veterans General Hospital and the College of Medicine, National Yang-Ming University, Taipei in Taiwan.
More articles on population health:
5 states where people get the best, worst sleep
Drug that helps people quit smoking ups cardiovascular event risk
Cigarette smoking on the rise among America’s drug users
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
